Kevin Tang - Director, 10%+ Owner at La Jolla Pharmaceutical Co

Insider Transactions and Holdings

Class	Price $	Transaction Date	Ownership	Underlying Class
Common Stock	$6.23	Aug 22, 2022	BY LP
Series C-1(2) Convertible Preferred Stock		Aug 22, 2022	BY LP	Common Stock
Stock Option (Right to Buy)		Aug 22, 2022	Direct	Common Stock

Showing 1 to 3 of 3 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.